Please use this identifier to cite or link to this item: http://192.168.1.35:80/jspui/handle/Hannan/30984
Title: A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
Authors: Starling, N;Okines, A;Cunningham, D;Allum, W;Wotherspoon, A;Benson, M;Thompson, J;Thomas, J;Brown, G;Riddell, A;Stavridi, F;Ashley, S;Oates, J;Chau, I
subject: Science & Technology
Life Sciences & Biomedicine
Oncology
Oncology
oesophageal adenocarcinoma
preoperative chemotherapy
pathological complete response
ADVANCED ESOPHAGOGASTRIC CANCER
ESOPHAGEAL CANCER
NEOADJUVANT THERAPY
COMPLETE RESPONSE
RANDOMIZED-TRIAL
CARCINOMA
Surgery
CHEMORADIOTHERAPY
FLUOROURACIL
survival
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Capecitabine
Cisplatin
Combined Modality Therapy
Deoxycytidine
Disease Progression
Epirubicin
Esophageal Neoplasms
Female
Fluorouracil
Follow-Up Studies
Humans
Male
Middle Aged
Stomach Neoplasms
Survival Rate
Humans
Adenocarcinoma
Esophageal Neoplasms
Stomach Neoplasms
Disease Progression
Cisplatin
Fluorouracil
Epirubicin
Deoxycytidine
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Survival Rate
Follow-Up Studies
Adult
Aged
Aged, 80 and over
Middle Aged
Female
Male
Science & Technology
Life Sciences & Biomedicine
Oncology
Oncology
oesophageal adenocarcinoma
preoperative chemotherapy
pathological complete response
ADVANCED ESOPHAGOGASTRIC CANCER
ESOPHAGEAL CANCER
NEOADJUVANT THERAPY
COMPLETE RESPONSE
RANDOMIZED-TRIAL
CARCINOMA
Surgery
CHEMORADIOTHERAPY
FLUOROURACIL
survival
Oncology & Carcinogenesis
Oncology And Carcinogenesis
Year: 5-May-2016
Publisher: Cancer Research UK
URI: http://localhost/handle/Hannan/30984
https://spiral.imperial.ac.uk:8443/handle/10044/1/32048
Standard no: 1532-1827
https://dx.doi.org/10.1038/sj.bjc.6605070
Type Of Material: Article
Appears in Collections:Department of Surgery and Cancer

Files in This Item:
Click on the URI links for accessing contents.


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.